Bysanti Tablet
Product Images NDC 43068-712
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 24 technical images submitted to the FDA as part of the official labeling for Bysanti (NDC 43068-712). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Vanda Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Chemical Structure (Milsaperidone 02)
Figure 1 (Milsaperidone 03)
This text appears to be a summary of pharmacokinetic data related to the effects of CYP2D6 and CYP3A4 inhibitors on the levels of milsaperidone and iloperidone, including Cmax and AUC values. It also includes mean effects and 90% confidence intervals for these inhibitors. The data suggests changes relative to a reference and provides numerical values for these changes. The text emphasizes the impact of the inhibitors on the pharmacokinetics of these medications.*
Figure 2 (Milsaperidone 04)
Figure 3 (Milsaperidone 05)
This text appears to be a table containing information about the number of patients in a study and the treatment groups, placebo and loperidone. It also mentions the least squares mean. The data includes numbers related to patients, time in days, and some numeric values. The information seems to be part of a study or research project.*
60 Tablets 1mg Bottle Label (Milsaperidone 06)
60 Tablets 2mg Bottle Label (Milsaperidone 07)
60 Tablets 4mg Bottle Label (Milsaperidone 08)
60 Tablets 6mg Bottle Label (Milsaperidone 09)
60 Tablets 8mg Bottle Label (Milsaperidone 10)
60 Tablets 10mg Bottle Label (Milsaperidone 11)
60 Tablets 12mg Bottle Label (Milsaperidone 12)
Titration Pack A Mockup (Milsaperidone 13)
The text provides information on a risperidone titration pack containing various doses of tablets. The pack includes two 1 mg tablets, two 2 mg tablets, two 3 mg tablets, and two 6 mg tablets. The product is distributed by Vanda Pharmaceuticals Inc. located in Washington, D.C. The National Drug Code (NDC) for this product is 43068-713-08. This pack is intended for prescription use only.*
Titration Pack B Mock-up (Milsaperidone 14)
Titration Pack C Mock-up (Milsaperidone 15)
14 Tablets 1mg Carton Label (Milsaperidone 16)
14 Tablets 1mg Bottle Label (Milsaperidone 17)
14 Tablets 6mg Carton Label (Milsaperidone 18)
14 Tablets 6mg Bottle Label (Milsaperidone 19)
14 Tablets 8mg Carton Label (Milsaperidone 20)
This text is detailing information about a medication called "Bysanti" which is in 8mg tablets. It provides instructions on how to store the medication and advises protecting it from light and moisture. The text mentions keeping the medication out of the reach of children. The lot number and expiration date are also listed.*
14 Tablets 8mg Bottle Label (Milsaperidone 21)
Titration Pack A Professional (Milsaperidone 22)
Titration Pack B Professional (Milsaperidone 23)
Titration Pack C Professional (Milsaperidone 24)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.